Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tie Yan Han"'
Autor:
Yong-Yu Liu, Tie Yan Han, Jing Yuan Yu, Arie Bitterman, Ahn Le, Armando E. Giuliano, Myles C. Cabot
Publikováno v:
Journal of Lipid Research, Vol 45, Iss 5, Pp 933-940 (2004)
High glucosylceramide synthase (GCS) activity is one factor contributing to multidrug resistance (MDR) in breast cancer. Enforced GCS overexpression has been shown to disrupt ceramide-induced apoptosis and to confer resistance to doxorubicin. To exam
Externí odkaz:
https://doaj.org/article/23122ba0868a4d80a9f4f8cedec65284
Autor:
Jing Yuan Yu, Myles C. Cabot, Armando E. Giuliano, Yong-Yu Liu, Arie Bitterman, Ahn Le, Tie Yan Han
Publikováno v:
Journal of Lipid Research, Vol 45, Iss 5, Pp 933-940 (2004)
High glucosylceramide synthase (GCS) activity is one factor contributing to multidrug resistance (MDR) in breast cancer. Enforced GCS overexpression has been shown to disrupt ceramide-induced apoptosis and to confer resistance to doxorubicin. To exam
Publikováno v:
The FASEB Journal. 15:719-730
Ceramide glycosylation, through glucosylceramide synthase (GCS), allows cellular escape from ceramide-induced programmed cell death. This glycosylation event confers cancer cell resistance to cytotoxic anticancer agents [Liu, Y. Y., Han, T. Y., Giuli
Publikováno v:
Journal of Biological Chemistry. 274:1140-1146
Multidrug-resistant cancer cells display elevated levels of glucosylceramide (Lavie, Y., Cao, H. T., Volner, A., Lucci, A., Han, T. Y., Geffen, V., Giuliano, A. E., and Cabot, M. C. (1997) J. Biol. Chem. 272, 1682-1687). In this study, we have introd
Publikováno v:
FEBS Letters. 431:185-188
In this study we demonstrate that the multidrug resistance (MDR) modulator PSC 833 is a potent agonist of ceramide metabolism. When added with [3H]serine or [3H]palmitic acid to the culture medium of MCF-7 cells, PSC 833, in a dose-responsive fashion
Autor:
Ralph C. Jones, Hui-ting Cao, Tie-Yan Han, Armando E. Giuliano, Myles C. Cabot, Zu-chuan Zhang, Yaakov Lavie
Publikováno v:
International Journal of Cancer. 70:567-574
The antiestrogen tamoxifen is widely used for endocrine therapy of breast cancer; however, the mechanisms of estrogen receptor-independent interactions of tamoxifen remain ill defined. Here we examine the effect of tamoxifen on the initial steps of c
Autor:
Valerie, Gouazé, Jing Y, Yu, Richard J, Bleicher, Tie-Yan, Han, Yong-Yu, Liu, Hongtao, Wang, Michael M, Gottesman, Arie, Bitterman, Armando E, Giuliano, Myles C, Cabot
Publikováno v:
Molecular cancer therapeutics. 3(5)
Resistance to natural product chemotherapy drugs is a major obstacle to successful cancer treatment. This type of resistance is often acquired in response to drug exposure; however, the mechanisms of this adverse reaction are complex and elusive. Her
Autor:
Hongtao Wang, Arthur E. Frankel, Myles C. Cabot, Scott H. Kaufmann, Tie Yan Han, Alex Senchenkov, Timothy Kottke
Publikováno v:
Blood. 98(6)
DT(388)-GM-CSF, a targeted fusion toxin constructed by conjugation of human granulocyte-macrophage colony-stimulating factor (GM-CSF) with the catalytic and translocation domains of diphtheria toxin, is presently in phase I trials for patients with r
Autor:
Anthony G. Charles, Nora M. Hansen, Armando E. Giuliano, Myles C. Cabot, Yong Y. Liu, Tie-Yan Han
Publikováno v:
Cancer chemotherapy and pharmacology. 47(5)
Purpose: Taxol has emerged as a valuable antimitotic chemotherapeutic agent, particularly in advanced breast and ovarian cancers. Although much is known about cytotoxic mechanisms, the effectiveness of Taxol cannot be solely explained by microtubular
Publikováno v:
The Journal of biological chemistry. 275(10)
Previous work from our laboratory demonstrated that increased competence to glycosylate ceramide conferred adriamycin resistance in MCF-7 breast cancer cells (Liu, Y. Y., Han, T. Y., Giuliano, A. E. , and M. C. Cabot. (1999) J. Biol. Chem. 274, 1140-